BRC Therapeutics Appoints Chandra Ramanathan as Executive Vice President of Commercialization and Strategy
Position
Executive Vice President
Company
BRC Therapeutics
CaliforniaBiotechnologyHealth CareTherapeuticsPharmaceuticalDescription
BRC Therapeutics has announced the appointment of Chandra Ramanathan, Ph.D., M.B.A., as their new Executive Vice President of Commercialization and Strategy. With over 30 years of experience in biopharmaceuticals, Ramanathan will lead the company's advancement in drug development and commercialization efforts.
Quick answer
BRC Therapeutics Appoints Chandra Ramanathan as Executive Vice President of Commercialization and Strategy (August 24, 2026). BRC Therapeutics is based in California, United States.
- Who is the new Executive Vice President at BRC Therapeutics?
- BRC Therapeutics named Chandra Ramanathan Executive Vice President, announced August 24, 2026.
- What did BRC Therapeutics announce on August 24, 2026?
- BRC Therapeutics has announced the appointment of Chandra Ramanathan, Ph.D., M.B.A., as their new Executive Vice President of Commercialization and Strategy. With over 30 years of experience in biopharmaceuticals, Ramanathan will lead the company's advancement in drug development and commercialization efforts.
- What does BRC Therapeutics do?
- BRC Therapeutics is a clinical-stage pharmaceutical company developing multimodal cannabinoid therapeutics for neurological and inflammatory conditions.
- Where is BRC Therapeutics based?
- BRC Therapeutics is based in California, United States.
- Which similar companies made leadership changes around the same time?
- Parabilis Medicines (August 25, 2026), Nurix Therapeutics (August 21, 2026), Azora Therapeutics, Inc. (DE) (August 29, 2026) and Arletta Pharma Solutions (September 1, 2026) also announced leadership changes within 45 days of BRC Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Parabilis Medicines Appoints Craig Tendler as Director (August 25, 2026)
- Nurix Therapeutics Appoints Wes Burwell as Chief Human Resources Officer (August 21, 2026)
- Adial Pharmaceuticals Appoints Matthew Davidson as President and CEO (August 29, 2026)
- Arletta Pharma Solutions Appoints Jeannette Jager-van Dijk as Chief Executive Officer (September 1, 2026)
- Olema Pharmaceuticals Appoints Jason O’Byrne as Chief Financial Officer (August 13, 2026)
- Abivax Appoints James Berger as Global Head of Marketing (September 7, 2026)
Who to call at BRC Therapeutics, and when
A new leader at BRC Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day BRC Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BRC Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BRC Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BRC Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
BRC Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.